Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
BACKGROUND
Patients with amnestic mild cognitive impairment (MCI) demonstrate decline in everyday function. In this study, we investigated whether whole brain atrophy and apolipoprotein E (APOE) genotype are associated with the rate of functional decline in MCI.


METHODS
Participants were 164 healthy controls, 258 MCI patients, and 103 patients with mild Alzheimer's disease (AD), enrolled in the Alzheimer's Disease Neuroimaging Initiative. They underwent brain MRI scans, APOE genotyping, and completed up to six biannual Functional Activities Questionnaire (FAQ) assessments. Random effects regressions were used to examine trajectories of decline in FAQ across diagnostic groups, and to test the effects of ventricle-to-brain ratio (VBR) and APOE genotype on FAQ decline among MCI patients.


RESULTS
Rate of decline in FAQ among MCI patients was intermediate between that of controls and mild AD patients. Patients with MCI who converted to mild AD declined faster than those who remained stable. Among MCI patients, increased VBR and possession of any APOE varepsilon4 allele were associated with faster rate of decline in FAQ. In addition, there was a significant VBR by APOE varepsilon4 interaction such that patients who were APOE varepsilon4 positive and had increased atrophy experienced the fastest decline in FAQ.


CONCLUSIONS
Functional decline occurs in MCI, particularly among patients who progress to mild AD. Brain atrophy and APOE varepsilon4 positivity are associated with such declines, and patients who have elevated brain atrophy and are APOE varepsilon4 positive are at greatest risk of functional degradation. These findings highlight the value of genetic and volumetric MRI information as predictors of functional decline, and thus disease progression, in MCI.
Okonkwo
Ozioma C
OC
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ozioma@jhmi.edu
Alosco
Michael L
ML
Jerskey
Beth A
BA
Sweet
Lawrence H
LH
Ott
Brian R
BR
Tremont
Geoffrey
G
D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications / Q000235:genetics / Q000473:pathology; D053327:Apolipoprotein E4 / Q000235:genetics*; D001284:Atrophy / Q000473:pathology; D001921:Brain / Q000473:pathology*; D002552:Cerebral Ventricles / Q000473:pathology; D003072:Cognition Disorders / Q000150:complications / Q000235:genetics / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009483:Neuropsychological Tests; D011569:Psychiatric Status Rating Scales; D013223:Statistics as Topic; D011795:Surveys and Questionnaires
D053327:Apolipoprotein E4
Invest Radiol. 2001 Sep;36(9):539-46
11547042
Neurology. 2005 Nov 8;65(9):1502-3
16275849
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9
9236950
Ann Neurol. 2009 Apr;65(4):403-13
19296504
Neuropsychology. 2008 Jul;22(4):531-44
18590364
Neurology. 2001 May 8;56(9):1143-53
11342678
Cereb Cortex. 2004 Jan;14(1):11-22
14654453
J Neuropathol Exp Neurol. 2008 Apr;67(4):261-70
18379441
Pharmacogenomics J. 2010 Oct;10(5):375-84
20029386
J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):249-65
17827410
Radiology. 2008 Aug;248(2):590-8
18574133
Neuroscience. 1995 Dec;69(3):757-61
8596645
N Engl J Med. 2005 Jun 9;352(23):2379-88
15829527
J Int Neuropsychol Soc. 2007 Sep;13(5):747-57
17521485
Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 3:14-22
10654095
J Gerontol. 1982 May;37(3):323-9
7069156
Neurobiol Aging. 2010 Sep;31(9):1601-5
18829136
Neurology. 2007 Oct 9;69(15):1528-35
17923615
Alzheimer Dis Assoc Disord. 2007 Jan-Mar;21(1):14-24
17334268
Neurology. 2003 Aug 26;61(4):487-92
12939422
J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):324-33
15860469
Neurology. 2002 Mar 12;58(5):758-64
11889240
Alzheimers Dement. 2005 Jul;1(1):55-66
17476317
Neurology. 2005 Oct 25;65(8):1227-31
16247049
J Magn Reson Imaging. 2008 Apr;27(4):685-91
18302232
Br J Psychiatry. 2006 Nov;189:399-404
17077428
Neuroimage. 1999 Feb;9(2):179-94
9931268
Neurology. 2006 Aug 8;67(3):461-6
16894108
Br J Radiol. 2002 Jun;75(894):506-13
12124237
Biol Psychol. 2000 Oct;54(1-3):35-54
11035219
Neurocase. 2005 Feb;11(1):3-7
15804918
Nat Rev Neurosci. 2008 Oct;9(10):768-78
18802446
Neurology. 2005 Jul 12;65(1):119-24
16009896
Neurology. 1984 Jul;34(7):939-44
6610841
CNS Drugs. 2004;18(13):853-75
15521790
J Gerontol B Psychol Sci Soc Sci. 2007 Jan;62(1):P3-P11
17284555
Neuron. 2001 Oct 25;32(2):181-4
11683989
J Int Neuropsychol Soc. 2004 May;10(3):442-52
15147601
Arch Neurol. 2000 Jun;57(6):877-84
10867786
CNS Spectr. 2008 Jan;13(1):45-53
18204414
Arch Neurol. 2002 Jul;59(7):1154-60
12117364
Neurobiol Aging. 2009 Mar;30(3):432-40
17869384
Neuron. 2002 Jan 31;33(3):341-55
11832223
Arch Neurol. 2000 Mar;57(3):312-4
10714654
J Cell Mol Med. 2008 Dec;12(6B):2762-71
18318693
J Gerontol A Biol Sci Med Sci. 2005 Oct;60(10):1319-23
16282567